Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Kiniksa Pharmaceuticals International (KNSA) SEC Filings & 10K Form

Kiniksa Pharmaceuticals International logo
$33.75 +0.17 (+0.51%)
Closing price 08/22/2025 04:00 PM Eastern
Extended Trading
$33.44 -0.31 (-0.92%)
As of 08/22/2025 07:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Kiniksa Pharmaceuticals International SEC Filings

Export to Excel
DateFilerForm TypeView
08/20/2025
3:36 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2025
4:13 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2025
3:36 PM		Kiniksa Pharmaceuticals International (Subject)
Malley Thomas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/13/2025
3:24 PM		Kiniksa Pharmaceuticals International (Subject)
Malley Thomas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2025
3:54 PM		Kiniksa Pharmaceuticals International (Subject)
Malley Thomas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/08/2025
3:35 PM		Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
4:37 PM		Kiniksa Pharmaceuticals International (Subject)
Paolini John F. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/06/2025
3:30 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
3:30 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2025
4:23 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2025
3:16 PM		Kiniksa Pharmaceuticals International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2025
6:30 AM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2025
6:44 PM		BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
Form SCHEDULE 13G/A
07/16/2025
3:30 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/14/2025
4:04 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2025
3:39 PM		Kiniksa Pharmaceuticals International (Issuer)
Levy Richard S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
3:39 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
4:23 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/11/2025
4:32 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
4:35 PM		Kiniksa Pharmaceuticals International (Issuer)
Quart Barry D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2025
3:39 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2025
4:46 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2025
3:50 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:53 PM		Kiniksa Pharmaceuticals International (Issuer)
Quart Barry D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:55 PM		Kiniksa Pharmaceuticals International (Issuer)
Popovits Kimberly J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:59 PM		Kiniksa Pharmaceuticals International (Issuer)
McCain Tracey L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
4:02 PM		Kiniksa Pharmaceuticals International (Issuer)
Malley Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
6:10 AM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025
3:30 PM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
4:25 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2025
4:23 PM		Kiniksa Pharmaceuticals International (Filer)
Form DEFA14A
05/22/2025
3:38 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
3:37 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:16 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/15/2025
3:39 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:32 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2025
4:13 PM		Kiniksa Pharmaceuticals International (Subject)
Patel Sanj K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
3:47 PM		Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:49 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:50 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:52 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This stock could leave NVDA in the dust (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla and Nvidia are all on the verge of major disruption. To help protect anyone with money invested in them, he's sharing three exciting stocks to replace them with. He gives away the names and tickers completely free in his brand-new "Sell This, Buy That" broadcast.tc pixel

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
05/05/2025
3:53 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:54 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:26 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
5:24 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2025
4:10 PM		Kiniksa Pharmaceuticals International (Subject)
Moat Ross (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2025
4:11 PM		Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2025
3:15 PM		Kiniksa Pharmaceuticals International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2025
6:40 AM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
6:47 PM		BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
Form SCHEDULE 13G/A
04/23/2025
3:31 PM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
3:44 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:30 PM		Kiniksa Pharmaceuticals International (Filer)
Form DEFA14A
04/16/2025
3:38 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2025
3:39 PM		Kiniksa Pharmaceuticals International (Filer)
Form PRE 14A
04/09/2025
3:41 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:42 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:43 PM		Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:44 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:45 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:45 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
5:57 PM		Kiniksa Pharmaceuticals International (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
Form SCHEDULE 13G
04/03/2025
4:06 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
3:52 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:35 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:48 PM		Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:49 PM		Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:50 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:51 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:52 PM		Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:53 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/17/2025
4:29 PM		Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
3:37 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/14/2025
3:38 PM		Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2025
3:47 PM		Kiniksa Pharmaceuticals International (Subject)
Megna Michael R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
3:37 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:13 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
3:31 PM		Kiniksa Pharmaceuticals International (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2025
3:15 PM		Kiniksa Pharmaceuticals International (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
6:31 AM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
2:45 PM		Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals International (Subject)
Form SCHEDULE 13G/A
02/10/2025
4:37 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:42 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2025
4:27 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:34 AM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
3:45 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2024
4:17 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
3:34 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
6:14 PM		Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
4:25 PM		Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2024
4:13 PM		Kiniksa Pharmaceuticals International (Subject)
Megna Michael R (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. tc pixel

Discover the under-the-radar project I believe will skyrocket as a result.
11/18/2024
4:50 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
3:32 PM		HHLR ADVISORS, LTD. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
Form SC 13G/A
11/13/2024
3:30 PM		Kiniksa Pharmaceuticals International (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13G/A
11/06/2024
3:11 PM		Kiniksa Pharmaceuticals International (Subject)
Patel Sanj K (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/29/2024
3:14 PM		Kiniksa Pharmaceuticals International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/29/2024
6:31 AM		Kiniksa Pharmaceuticals International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2024
3:11 PM		BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
Form SC 13G
10/17/2024
3:35 PM		Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:57 PM		Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:KNSA) was last updated on 8/25/2025 by MarketBeat.com Staff
From Our Partners
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
The $7 company helping Nvidia build the world’s first trillion-dollar robot …
Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...
Weiss Ratings | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel